← All stocks

Progyny, Inc.

PGNY Net selling
CIK 0001551306 #2051 in the set updated 17 Sep 2026
Bought (120 mo)
$8.17M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.18B
$3.60M on a plan · $282.47M straight out of an exercise
Sold at will
$892.57M
1041 of 1582 sales
Net
−$1.17B
−$884.41M against sales at will

By person

26 insiders · 1,613 transactions
31.0×

Peter Anevski holds 31.0 times base salary in stock. $26.98M of shares against $870.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Peter Anevski last reported holding, valued at $27.94, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
TPG Group Holdings (SBS) Advisors, Inc. entity
10% owner
$438.17M (165)
−$438.17M
10,000,000
$279.44M
+740.3%
Schlanger David J
Executive Chairman
$2.20M (1)
$238.24M (246) scheduled
−$236.04M
238,462
$6.66M
−77.6%
TPG GP A, LLC entity
Former 10% Owner
$148.19M (2)
−$148.19M
6,350,000
$177.45M
−36.5%
Anevski Peter
CHIEF EXECUTIVE OFFICER
$4.96M (2)
$140.21M (319)
−$135.24M
965,614
$26.98M
−60.0%
GSK plc entity
10% owner
$103.00M (1)
−$103.00M
6,238,244
$174.32M
+1,396%
Payson Norman
Director
$83.12M (725)
−$83.12M
2,938,283
$82.11M
−7.2%
Livingston Mark S.
CHIEF FINANCIAL OFFICER
$7.06M (24) scheduled
−$7.06M
72,453
$2.02M
+555.6%
Bealer Jennifer
EVP, GENERAL COUNSEL
$5.97M (40) scheduled
−$5.97M
193,825
$5.42M
+110.8%
Ajmani Karin
EVP, Chief of Strategic Dev.
$4.69M (1)
−$4.69M
1,128,560
$31.54M
+48.9%
SEIDENBERG BETH C
Director
$1,000.00K (1)
$3.80M (5)
−$2.80M
215,521
$6.02M
Sturmer Michael E
PRESIDENT
$2.06M (11) scheduled
−$2.06M
255,205
$7.13M
−3.3%
Greenbaum Lisa
EVP, Chief Client Officer
$1.32M (16) scheduled
−$1.32M
11,746
$328.23K
+660.8%
KLEINER PERKINS CAUFIELD & BYERS XIII, LLC entity
10% owner
$912.15K (2) scheduled
−$912.15K
7,435,609
$207.78M
+1,083%
GORDON KEVIN K
Director
$657.63K (5)
−$657.63K
21,819
$609.71K
Scott Cheryl
Director
$507.69K (6)
−$507.69K
19,772
$552.51K
Swartz Allison
EVP, GC
$382.21K (11) scheduled
−$382.21K
79,719
$2.23M
Cummings Melissa B
Chief Operating Officer
$310.36K (2) scheduled
−$310.36K
69,934
$1.95M
Clapp Geoffrey
Chief Product Officer
$39.14K (1) scheduled
−$39.14K
59,828
$1.67M
+108.5%
Park Jeffrey G
Director
39,981
$1.12M
HOLSTEIN ROGER C
Director
28,729
$802.81K
Dean Lloyd H
Director
26,519
$741.05K
Cohen Fred E
Director
22,693
$634.14K
MORRIS DEBRA L
Director
5,660
$158.16K
Bierbower Elizabeth D
Director
5,660
$158.16K
Clinton Malissia
Director
2,210
$61.76K
KPCB XIII Associates, LLC entity
10% owner
0
$0.00
−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Payson Norman
14 Nov 2025
Director
Exercised, kept
36,224
$1.45
$52.52K
Showing 250 of 1,613 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 648
Amendments (4/A) skipped 13
Filings about a different issuer 0
Unreadable filings 0
Joint filings 68
Sales on a Rule 10b5-1 plan 31
Sales straight out of an exercise 510
Sales at will 1,041
Transactions with no price 0
Shares from compensation/vesting 124,754,210
Sales filed before the plan box existed 1,033
History held since 24 Oct 2019